2582-31-2 Usage
Uses
Used in Organic Synthesis:
2,5-Cyclohexadien-1-one, 4-[(4-hydroxy-2-methylphenyl)imino]is used as a reagent in organic synthesis for the preparation of various organic compounds. Its unique structure and reactivity make it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Production:
2,5-Cyclohexadien-1-one, 4-[(4-hydroxy-2-methylphenyl)imino]is used in the production of pharmaceuticals due to its potential therapeutic properties. Its antioxidant and metal-chelating abilities make it a candidate for the development of drugs targeting various medical conditions.
Used in Antioxidant Applications:
2,5-Cyclohexadien-1-one, 4-[(4-hydroxy-2-methylphenyl)imino]is used as an antioxidant in various industries, including food, cosmetics, and pharmaceuticals. Its ability to neutralize free radicals and prevent oxidative damage makes it a valuable additive in these applications.
Used in Metal Chelation:
In the medical and industrial fields, 2,5-Cyclohexadien-1-one, 4-[(4-hydroxy-2-methylphenyl)imino]is used for its metal-chelating properties. It can bind to metal ions, making it useful in applications such as detoxification, water treatment, and the development of metal-based drugs.
Used in Research and Development:
2,5-Cyclohexadien-1-one, 4-[(4-hydroxy-2-methylphenyl)imino]is also used in research and development for studying its potential applications and properties. Its unique structure and reactivity make it an interesting subject for scientific investigations, which may lead to the discovery of new uses and applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 2582-31-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,8 and 2 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2582-31:
(6*2)+(5*5)+(4*8)+(3*2)+(2*3)+(1*1)=82
82 % 10 = 2
So 2582-31-2 is a valid CAS Registry Number.
